Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
adrenal cortex neoplasms
MeSH D000306 - adrenal cortex neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000310:
Adrenal gland neoplasms
0 Companies
0 Drugs
Success rate
D000303:
Adrenal cortex diseases
0 Companies
0 Drugs
Success rate
D000306:
Adrenal cortex neoplasms
1 Company
1 Drug
$
Success rate
D018246:
Adrenocortical adenoma
0 Companies
0 Drugs
Success rate
D018268:
Adrenocortical carcinoma
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
HRA Pharma
Mitotane
Lysodren
2004-04-28
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/2
Phase 2
0
%
0/6
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use